The Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand

Citation

Faunce, T, Johnston, K & Bambrick, H 2006, 'The Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand', Victoria University of Wellington Law Review, vol. 37, no. 3, pp. 365-389.

Year

2006

Field of Research

  • Access To Justice

Updated:  08 December 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers